Elevance Health earnings were $5.0B for the trailing 12 months ending Jun 30, 2026, with -4.2% growth year over year. The latest ELV earnings report on Jun 30, 2026 announced Q2 2026 earnings of $1.5B, down 17.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ELV reported annual earnings of $5.7B, with -5.3% growth.
ELV past earnings growth
How has ELV's earnings growth performed historically?
What were Elevance Health's earnings last quarter?
On ELV's earnings call on Jul 15, 2026, Elevance Health (NYSE: ELV) reported Q2 2026 earnings per share (EPS) of $6.74, up 12.92% year over year. Total ELV earnings for the quarter were $1.46 billion. In the same quarter last year, Elevance Health's earnings per share (EPS) was $7.74.
As of the last Elevance Health earnings report, Elevance Health is currently profitable. Elevance Health's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $4.96 billion, a 7.41% decrease year over year.
What was ELV's earnings growth in the past year?
As of Elevance Health's earnings date in Jul 15, 2026, Elevance Health's earnings has grown -4.19% year over year. This is 26.44 percentage points higher than the US Healthcare Plans industry earnings growth rate of -30.63%. ELV earnings in the past year totalled $4.96 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.